Bioinformatics: Computers or clinicians for complex disease risk assessment?

[1]  P. Sebastiani,et al.  Bayesian Machine Learning and Its Potential Applications to the Genomic Study of Oral Oncology , 2003, Advances in dental research.

[2]  James G. Taylor VI,et al.  Patterns of low‐affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease , 2002, American journal of hematology.

[3]  Hay,et al.  The methylenetetrahydrofolate reductase gene C677T polymorphism in patients with homozygous sickle cell disease and stroke , 1999, British journal of haematology.

[4]  R. Ware,et al.  Inherited DNA mutations contributing to thrombotic complications in patients with Sickle cell disease , 1998, American journal of hematology.

[5]  V. Arruda,et al.  Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahidrofolate reductase among patients with sickle cell disease in Brazil , 1998 .

[6]  A. Kutlar,et al.  Are sickle cell disease patients with stroke genetically predisposed to the event by inheriting a tendency to high tumor necrosis factor levels? , 1998, American journal of hematology.

[7]  F. Costa,et al.  Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. , 1998, American journal of hematology.

[8]  Scott T. Miller,et al.  Cerebrovascular accidents in sickle cell disease: rates and risk factors. , 1998, Blood.

[9]  C. Leissinger,et al.  Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease , 1997, American journal of hematology.

[10]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.